Clinical Trials Directory

Trials / Completed

CompletedNCT00940654

The Fever and Antipyretic in Critically Illness Evaluation Study

Status
Completed
Phase
Study type
Observational
Enrollment
1,426 (actual)
Sponsor
Japanese Society of Intensive Care Medicine · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The purpose of this multination multicenter observational study is to determine the impact of fever and antipyretic on outcomes in critically ill patients.

Detailed description

Fever is common in critically ill patients.Antipyretic therapy for fever is routinely performed in intensive care.There are studies to assess the relationship between fever and mortality in non-neurological ICU. However, all of them did not have any information of antipyretic therapy. There are two small, single center RCT, which suggested a potential risk for antipyretic therapy. Thus, a large RCT might be ethically difficult. It is unfortunate that there is not enough information on how the investigators should control body temperature in non-neurological critically ill patients, because fever is a very common physiological abnormality in this cohort. From the beginning, it would, therefore, be desirable to understand several aspects of fever and antipyretic therapy in ICU patients, as 1)How often fever occurs in our ICUs, 2)To what degree fever is independently associated with mortality?, 3)How often antipyretic therapy is prescribed?, 4)How effectively antipyretic can decrease temperature?, 5)How different is lowering temperature with medications compared with cooling?, 6)To what degree antipyretic is independently associated with mortality? Thus, the investigators plan to address these questions by conducting a multi-national multi-center prospective observational trial, named "The Fever and Antipyretic in Critically illness evaluation study" (The FACE study)

Conditions

Interventions

TypeNameDescription
OTHERAntipyretic therapyExternal cooling;Internal cooling;Non steroid anti inflammatory drugs; Acetaminophen; Steroid

Timeline

Start date
2009-09-01
Primary completion
2009-12-01
Completion
2009-12-01
First posted
2009-07-16
Last updated
2010-05-19

Locations

2 sites across 2 countries: Japan, South Korea

Source: ClinicalTrials.gov record NCT00940654. Inclusion in this directory is not an endorsement.